You are here:

quetiapine (Seroquel XL)

Advice

in the absence of a submission from the holder of the marketing authorisation

quetiapine (Seroquel XL®) is not recommended for use within NHS Scotland.

Indication: Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD) who have had sub-optimal response to antidepressant monotherapy.

The holder of the marketing authorisation has not made a submission to SMC regarding this product in this indication.  As a result we cannot recommend its use within NHSScotland.

Drug Details

Drug Name: quetiapine (Seroquel XL)
SMC Drug ID: 744/11
Manufacturer: AstraZeneca UK Ltd
Indication: Add-on treatment of major depressive episodes in patients with Major Depressive Disorder (MDD)
BNF Category:
Sub Category: 4.2 Drugs used in psychoses and related disorders
Submission Type: Non submission
Status: Not Recommended
Date Advice Published: 10 October 2011

Back